跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Depofemme - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Depofemme
Approved
STANDARD
Depofemme
PT Triyasa Nagamas Farma
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
c22d2bfaa187a172
Company
PT Triyasa Nagamas Farma
Type
Standard
Approval Details
Approval Id
c22d2bfaa187a172
Drug Approval Philippines Name
Depofemme
Product Name
Depofemme
Registration Number
DR-XY40409
Brand Name
Depofemme
Generic Name
Medroxyprogesterone Acetate
Dosage Form
Suspension For Injection (I.M.)
Dosage Strength
150 mg/mL
Manufacturer
PT Triyasa Nagamas Farma
Importer
Nurturemed Pharma Inc.
Issuance Date
25 July 2022
Expiry Date
16 November 2027
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
c22d2bfaa187a172
Type
Standard
Back to Philippines FDA Approvals